BMO Capital analyst Evan Seigerman has reiterated their bullish stance on GPCR stock, giving a Buy rating on November 5. Evan Seigerman has ...

Merck has signed a licensing agreement worth up to $3.3 billion with Shanghai-based LaNova Medicines to develop, make and ...

In a report released yesterday, Evan Seigerman from BMO Capital maintained a Buy rating on Schrodinger (SDGR – Research Report), with a ...

Analysts cited data from a phase one study showing the highest dose of Amgen’s MariTide was linked to roughly 4% loss of bone ...

US pharma group says patients who took Emraclidine in clinical trials failed to show a significant decline in symptoms ...

From drug pricing to reforming the drug regulatory process, Trump’s re-election has plenty of implications for the pharma ...

BMO Capital Markets analyst Evan Seigerman in a note to investors called Gilead’s third-quarter performance “consistent” and ...

Evan Montvel-Cohen, who appeared in federal court on Tuesday to be re-sentenced after a successful appeal to the Ninth Circuit Court of Appeals, could get an even lower sentence than what he had ...

On Tuesday night, millions of Americans watched as former president Donald J. Trump gathered up enough electoral votes needed ...

The character who appeared was played by none other than Evan Peters, who had portrayed Quicksilver in the Fox Marvel universe. This appearance indicated that the Fox X-Men characters were already ...

Powerful weight-loss drugs like Wegovy and Zepbound have driven nearly $1 trillion in market-capitalization gains, with most ...

Analysts have struggled to estimate the size of the compounded market for weight-loss drugs because their sale is not tracked ...